Parallel Health World News Logo

Parallel Health World

cropper
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
September 04.2025
1 Minute Read

Stop Waiting—computer-aided diagnosis Solutions That Could Save You Today

Did you know that over 80% of medical errors are linked to misdiagnosis? With numbers like these, waiting for traditional methods is no longer an option. Computer-aided diagnosis solutions are not just futuristic dreams—they are already changing the way patients receive care and could save lives today. In this comprehensive guide, we explore how modern CAD systems, fueled by artificial intelligence and neural networks, are revolutionizing medical image analysis, boosting detection rates, and setting new standards in clinical practice.

Medical imaging lab with clinicians using computer-aided diagnosis, screens displaying diagnostic medical images

Introducing computer-aided diagnosis: Why the Future of Aided Diagnosis Is Already Here

The stakes in diagnostic medicine have never been higher. Each year, missed or late diagnoses result in countless patient complications and unnecessary loss of life. Enter computer-aided diagnosis (CAD): a transformative blend of machine learning, advanced image processing, and expert system design. CAD systems offer doctors a powerful second opinion by highlighting subtle patterns and potential issues in medical images—details that might escape the human eye. CAD applications now span across early lung nodule and breast cancer detection, to interpreting complex CT scans and chest radiographs. With an increasing wave of technological advancements, it’s clear that these tools are not just supplementary aids but essential diagnostic partners, promising safer, more accurate patient outcomes starting today.

"Over 80% of medical errors stem from misdiagnosis—can computer-aided diagnosis change this number for the better?"

What You'll Learn About computer-aided diagnosis and Modern Aided Diagnosis

  • The definition and core principles of computer-aided diagnosis
  • How computer aided detection impacts medical image analysis
  • Key technologies behind CAD systems (including neural network and artificial intelligence)
  • Applications in lung cancer, lung nodules, breast cancer, and more
  • Current limitations and future prospects

What Is computer-aided diagnosis? Aided Diagnosis in the Modern Clinical Practice

Infographic illustrating the evolution of computer-aided diagnosis from manual review to AI-assisted analysis in clinical practice

Defining computer-aided diagnosis and Aided Diagnosis

Computer-aided diagnosis refers to the integration of computational tools to assist radiologists and clinicians in interpreting medical images and making diagnoses. Unlike traditional review methods, CAD leverages pattern recognition and image data algorithms to flag abnormalities, highlight areas for further investigation, and provide preliminary diagnostic suggestions. By applying methodologies rooted in computer vision and machine learning, these systems aim to minimize false positive and false negative rates, improving overall detection rates. The core principles revolve around enhancing accuracy, consistency, and efficiency, transforming the role of the radiologist from sole interpreter to strategic decision-maker supported by data-driven insights.

How computer-aided diagnosis Evolved: From Manual to AI-Powered Solutions

The journey of computer-aided diagnosis began with basic digital enhancements and progressed through rule-based expert systems designed to follow predetermined diagnostic paths. The real breakthrough came with the adoption of machine learning technologies, particularly neural networks capable of learning from vast amounts of image data. Today’s CAD systems utilize artificial intelligence to process complex datasets, constantly updating their detection algorithms based on new clinical trial results and real-world feedback. This evolution has not only increased diagnostic accuracy but also introduced scalability and speed. AI-powered CAD is now reshaping standards in clinical practice, making early detection the expectation rather than the exception.

"The leap from manual image processing to AI-driven CAD systems has redefined medical accuracy."

The Role of computer-aided diagnosis in medical image Analysis and Aided Detection

Radiologists analyzing chest x-rays with computer-aided diagnosis, highlighting areas of interest with digital overlays

How computer aided Detection Supercharges Medical Image Review

One of the most critical applications of computer-aided diagnosis is its ability to “supercharge” the review of medical images. Traditional image analysis relies on human expertise, which, despite being highly skilled, is vulnerable to fatigue and cognitive bias. CAD harnesses image processing technologies and artificial neural networks to automatically scan images for risky patterns, such as potential lung nodules or suspicious masses in breast tissue. By marking these areas for the attention of a radiologist, computer aided detection not only improves the detection rate of diseases like lung cancer and breast cancer but also reduces missed findings in routine assessments. This synergy of human interpretation and AI-backed review sets a new bar for thorough, evidence-based diagnosis and ultimately leads to better patient outcomes.

From Chest Radiograph to Complex Diagnostics: Where computer-aided diagnosis Excels

Initial success stories for computer-aided diagnosis emerged in the interpretation of chest radiographs, where CAD systems assist radiologists in identifying early signs of pulmonary disease or lung cancer. Over time, CAD adoption has expanded to sophisticated modalities such as CT scans and mammography for breast cancer detection. These tools are proven to excel in areas where the sheer volume of images challenges even the most seasoned specialists. More recently, CAD is evolving to handle complex diagnostics, including cardiovascular disease, prostate cancer, and even neurological disorders, solidifying its reputation as a versatile ally across major areas of modern medicine and diagnostic imaging.

Chest Radiographs and Detection Rates: Improving Early Diagnosis

Chest radiographs, due to their widespread use in screening for lung diseases, were among the first to benefit from computer-aided detection. CAD systems meticulously scan these images, flagging subtle changes indicative of pulmonary nodules or early-stage lung cancer. Several clinical trial studies report a marked increase in the early detection rate, with some systems boosting accuracy by as much as 20% compared to unaided human review. Not only does this mean that more treatable conditions are caught early, but it also allows radiologists to dedicate more time to complex cases, elevating the efficiency and overall standard of diagnostic care for every patient.

How computer-aided diagnosis Solutions Work: Core Technologies and CAD Systems

Neural network visualization overlaying medical brain scan to illustrate computer-aided diagnosis technology

Neural Networks, Machine Learning, and Artificial Intelligence in computer-aided diagnosis

At the heart of every modern computer-aided diagnosis platform lies a combination of machine learning methods and neural network architectures. These systems train on vast libraries of labeled medical images, learning to distinguish between healthy and abnormal findings based on patterns in image data. Advanced artificial intelligence enables the software to continuously refine its analysis capabilities, always improving its sensitivity and specificity. This ongoing learning process has made CAD essential in settings where precision is critical. Not only can AI-based CAD systems process thousands of images far faster than humans, but they also consistently surface subtle anomalies that might otherwise evade early detection.

The CAD System: Components and Functionality

A typical CAD system comprises several integrated modules: image acquisition (connecting directly to modalities like CT and x-ray); image processing (enhancement, filtering, segmenting structures of interest); feature extraction (identifying pattern changes associated with disease); and decision-support algorithms (reporting findings and raising alerts). Sophisticated cad algorithms can work across multiple image types, supporting early lung nodule or breast lesion identification. User-friendly interfaces allow clinicians to review flagged results alongside the original studies, facilitating a seamless workflow that boosts diagnostic accuracy and helps minimize both false positive and false negative outcomes.

Image Processing and Aided Detection Methods

Modern image processing and aided detection methods are the backbone of CAD systems. Using a sequence of enhancement, segmentation, and pattern recognition steps, these systems convert raw image data into actionable insights. Convolutional neural networks, a class of deep learning, play a central role in identifying even the smallest irregularities—a vital function in detecting early-stage lung nodules or suspicious masses in breast tissue. By providing probability scores and clear visualizations, CAD empowers clinicians to validate findings and make more confident, data-driven diagnostic decisions.

Comparison of computer-aided diagnosis Technologies (AI, CAD, Traditional Methods)
Technology Detection Rate Speed User Involvement Adaptability
Traditional Manual Review Moderate, variable Low High Low (requires retraining for new protocols)
Traditional CAD System High for targeted findings Moderate Medium Moderate
AI-based CAD (Deep Learning/Neural Network) Highest (improving over time) High Low (after initial setup) High (self-learning, scalable)

Key Applications of computer-aided diagnosis: Lung Cancer, Breast Cancer, and Beyond

Displays comparing computer-aided diagnosis results for lung nodules and breast cancer in a modern clinical setting

computer-aided diagnosis in Detecting Lung Nodules and Lung Cancer

Detecting lung nodules early is crucial in the battle against lung cancer. Specially designed CAD systems are trained to scrutinize CT scans and chest radiographs for subtle signs that might indicate pre-cancerous or cancerous growths. Studies have demonstrated that these systems increase the detection rate for small or otherwise easily missed nodules without overburdening clinicians with excessive false positives. By integrating CAD into the routine review process, radiologists can confidently catch abnormalities at stages where treatment is more likely to be successful, effectively lowering mortality rates associated with late-stage lung disease.

Case Study: Improving Lung Cancer Detection Rates

A recent multicenter clinical trial involving over 1,000 patients illustrated the tangible benefits of computer-aided detection for pulmonary nodules. The study found that when radiologists used a CAD system as a second reader, the sensitivity for identifying early-stage lesions improved by more than 15%. Importantly, the CAD alerts also prompted clinicians to revisit ambiguous areas, reducing false negative diagnoses. This case underscores how the combination of expert human review and AI-powered aided detection translates directly into improved prognosis for patients facing serious diseases.

computer-aided diagnosis for Breast Cancer Screening: Advantages and Challenges

Breast cancer screening is another area revolutionized by computer aided technologies. Modern CAD algorithms embedded in mammography software help identify microcalcifications, masses, and structural distortions, all indicators of both benign and malignant pathology. CAD enhances the detection of breast cancer in dense tissue and supports double-reading workflows, where two experts independently assess the same images. However, despite the increase in overall detection rates, challenges remain. Elevated false positive rates can lead to patient anxiety and unnecessary follow-ups, highlighting the need for continual advancement in deep learning and neural network strategies to balance sensitivity and specificity.

The Impact of computer-aided diagnosis on Clinical Practice and Patient Outcomes

Clinical team celebrates improved diagnostic accuracy with computer-aided diagnosis systems

How computer aided Improves Accuracy and Efficiency in Medical Practices

The integration of computer-aided diagnosis technology in clinical environments is transforming the workflow, minimizing routine drudgery, and maximizing time spent on complex cases. By automating parts of the image processing and screening process, CAD systems enable radiologists and clinicians to review more images in less time without sacrificing diagnostic quality. Many facilities report reductions in diagnostic turnaround, more consistent reporting, and better patient outcomes. CAD also serves as a valuable training tool for junior doctors, helping them calibrate their interpretation skills against AI-generated predictions. This fusion of human expertise and algorithmic support is driving a new era of precision medicine.

Reducing Human Error with computer-aided diagnosis—A Statistical View

A large body of evidence supports the notion that computer-aided diagnosis dramatically reduces both false positive and false negative rates in high-volume screening programs. For example, analyses across several major U.S. hospitals found that CAD-assisted workflows decreased missed diagnoses by more than 10% in chest radiograph review and up to 15% in breast cancer screenings. As CAD platforms become more sophisticated, many experts now view these tools as a necessary “second set of eyes,” especially valuable for identifying rare or subtle anomalies that otherwise might be overlooked in routine clinical review. With such improvements, patients benefit from greater safety and a significantly higher standard of care.

"CAD systems are rapidly becoming the second set of eyes every radiologist needs."

Challenges and Limitations Facing computer-aided diagnosis Adoption

Barriers in Integration: From Cost to Workflow Disruption

Clinicians and administrators discussing computer-aided diagnosis implementation challenges

While the benefits of computer-aided diagnosis are clear, implementation still faces notable hurdles in many healthcare settings. Up-front costs for hardware, software, and integration can be significant, especially for institutions with tight budgets. Workflow disruption is another challenge, as clinicians must adapt to new reporting procedures and additional review steps introduced by CAD systems. There’s also the “trust gap”—some experienced radiologists may be reluctant to rely on machine learning and AI-powered outputs over years of clinical judgment. To reap the full rewards of these technologies, institutions must thoughtfully manage change, ensuring robust training and clear communication throughout the rollout.

Balancing AI Assistance with Clinical Expertise in computer aided Environments

Striking the right balance between AI-driven recommendations and the nuanced expertise of seasoned clinicians is essential for successful CAD adoption. No matter how advanced, current CAD technology should serve as an aid—not a replacement—for clinical decision-making. Robust protocols must be established so that AI-generated alerts always undergo human review before patient care decisions are made. As artificial intelligence and neural networks continue to progress, ongoing evaluation in multi-center clinical trials will help ensure that technology enhances, rather than hinders, the best practices in patient care.

Recent Advances in computer-aided diagnosis: The Promise of AI, Neural Networks, and Deep Learning

Scientists exploring deep learning and neural network advances in computer-aided diagnosis research lab

Breakthroughs in artificial intelligence and Deep Learning for Aided Detection

The latest generation of computer-aided diagnosis technologies is powered by sophisticated deep learning systems capable of self-improving through continued exposure to large and varied medical image datasets. Advanced neural network architectures like convolutional neural networks (CNNs) now outperform traditional CAD algorithms in key benchmarks for disease detection, notably lung cancer and breast cancer screening. AI-driven platforms are rapidly shortening the gap between research breakthroughs and clinical implementation by automating feature extraction, reducing manual bias, and continually improving diagnostic speed and accuracy.

Enabling Early Detection: computer-aided diagnosis for Proactive Healthcare

One of the most exciting areas of computer aided progress is the shift toward truly proactive healthcare. Rather than relying solely on symptomatic presentation, AI-powered CAD systems now empower clinicians to detect disease at its earliest—often pre-symptomatic—stages. This shift has enormous implications for public health, as conditions like lung cancer and breast cancer are demonstrably easier to treat and often curable when caught early. By supporting annual screening programs, risk stratification, and even home-based screening tools, modern CAD is poised to anchor a new era of preventative, personalized medicine.

Watch: How computer-aided diagnosis Detects Disease – Animation demonstrating AI-powered medical image analysis.

Step-by-Step: Implementing computer-aided diagnosis in Your Facility

Assessing Readiness and Clinical Practice Needs

Clinicians evaluating readiness for computer-aided diagnosis in hospital planning session

Before rolling out a computer-aided diagnosis solution, thorough readiness assessment is crucial. Begin by evaluating your institution’s technological infrastructure—are imaging workflows digital, and are networking and storage capable of supporting high-volume medical image exchange? Next, assess the clinical needs: Which specialties (radiology, oncology, pulmonology) stand to benefit most from AI-enhanced review? Engage stakeholders early to address trust, training, and workflow adaptation concerns. Run pilot programs, measure performance improvements, and gather feedback to iteratively refine the integration process. Thoughtful preparation ensures the smoothest transition and maximizes the return on investment for advanced CAD systems.

Selecting the Right CAD System for Medical Image Analysis

Choosing the most suitable CAD system requires an evidence-based approach. Prioritize vendors with proven track records in lung cancer, lung nodule analysis, or breast cancer detection. Carefully evaluate each software’s detection rate, integration capabilities with existing PACS (Picture Archiving and Communication Systems), regulatory certifications, and upgrade paths. Solutions offering explainable AI and customization options tend to work best for large multi-specialty facilities, while cloud-based CAD may provide rapid adoption for smaller clinics seeking cost-effective deployment. Vendor trials, references, and head-to-head comparisons are invaluable to ensure the system fits the specific clinical and technical landscape of your practice.

Staff Training: Integrating computer-aided diagnosis Efficiently

A successful CAD rollout hinges on comprehensive staff training. Tailored sessions should encompass not only the technical operation of the system but also interpretation of AI-generated findings and understanding of key clinical practice workflow adjustments. Encourage cross-disciplinary learning—radiologists, technologists, and IT experts must collaborate to streamline troubleshooting and optimize efficiency across departments. Simulation cases and regular feedback cycles help staff gain confidence and trust in the system. As ongoing advances in neural network and machine learning capabilities evolve, it’s essential to provide continuous education so your team remains at the leading edge of diagnostic excellence.

Checklist: Must-Have Features in computer aided Platforms

  • Seamless integration with PACS and EMR systems
  • High detection rate for target pathologies (e.g., lung nodules, breast lesions)
  • AI explainability and transparency
  • Intuitive user interface for radiologists and clinicians
  • Scalable infrastructure (on-premise or cloud-based)
  • Robust vendor support & training resources

People Also Ask About computer-aided diagnosis

Doctors and patients discussing computer-aided diagnosis questions around a digital tablet

What is the meaning of computer aided diagnosis?

Computer-aided diagnosis refers to the use of computers and specialized algorithms to assist medical professionals in interpreting medical images, flagging potential abnormalities, and supporting diagnostic decision-making. By analyzing chest radiographs, CT scans, and other modalities, CAD systems help clinicians improve diagnostic accuracy and reduce errors for conditions like lung cancer and breast cancer.

What is CAD in radiology?

In radiology, CAD stands for computer-aided detection or diagnosis. It employs computer algorithms to highlight or identify suspicious findings, such as lung nodules or developing tumors, in radiological images. This aids radiologists in detecting diseases earlier and more consistently, especially in high-volume screening programs.

Is computer aided diagnosis AI?

Modern computer-aided diagnosis systems are fundamentally built on artificial intelligence and machine learning technologies. These systems use AI-based neural networks and pattern recognition techniques to analyze complex medical images and assist clinicians in identifying disease pathologies accurately and efficiently.

How is CAD used in the medical field?

CAD is widely used in the medical field for analyzing chest radiographs, detecting lung nodules, screening for breast cancer through mammography, and supporting a wide range of applications that benefit from aided diagnosis. CAD integrations in modern diagnostic workflows allow healthcare professionals to catch early-stage disease and improve patient outcomes.

Watch: Inside a CAD System – Clinical radiologist explains the real-world impact of computer-aided diagnosis.

FAQs on computer-aided diagnosis and CAD System Use

How accurate is computer-aided diagnosis for cancer detection?

Computer-aided diagnosis systems can significantly boost sensitivity and specificity in cancer detection when used as a “second reader,” particularly for lung cancer and breast cancer screening programs. Most AI-driven platforms now match or exceed the diagnostic accuracy of unaided radiologists in controlled studies, especially for early-stage disease. However, final review and integration of CAD findings with clinical context are essential for the best patient outcomes.

Do artificial intelligence-based CAD systems replace human radiologists?

No, AI-based CAD systems are designed to support, not replace, expert human clinicians. They augment radiologists by flagging potential findings and reducing fatigue-related oversight. Clinical expertise remains critical for contextual interpretation, patient communication, and holistic care decisions. The hybrid model of AI and human review consistently yields the safest, most effective outcomes.

What are the risks and benefits of computer-aided diagnosis in clinical practice?

The major benefit is improved detection accuracy and efficiency—helping to catch disease early and reduce medical errors. Risks include potential workflow disruptions, reliance on over-sensitive AI systems (potential for false positives), and necessitating ongoing clinician training. However, with proper implementation and regular review, the benefits of CAD far outweigh the risks in most clinical scenarios.

Which medical image types benefit most from computer aided detection?

Chest radiographs (chest x-rays), CT scans for lung nodules or pulmonary nodules, and mammography images for breast cancer screening benefit most from CAD solutions. Improvements in neural network and machine learning also promise to bring increased accuracy to MRI, ultrasound, and other modalities in the near future.

Watch: Future Trends in computer-aided diagnosis – Experts discuss where AI and CAD are headed next.

Key Takeaways: computer-aided diagnosis Is Changing the Diagnostic Landscape

  • computer-aided diagnosis significantly boosts detection rates and accuracy
  • Applications in lung cancer, breast cancer, and beyond show superior outcomes
  • Integration challenges remain, but technology and clinical practice are converging fast

Conclusion: Don’t Wait for Tomorrow—Adopt computer-aided diagnosis for Safer, Smarter Diagnostics Today

The future of accurate, proactive medical care is already here. Don’t wait for misdiagnosis—embrace computer-aided diagnosis and deliver better, safer care today.

AI In Healthcare

81 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
08.05.2026

Unlocking Innovation: AAMI Introduces neXus 2027 Advisory Council

Update AAMI Unveils Its Vision for neXus 2027 Conference The Association for the Advancement of Medical Instrumentation (AAMI) has officially announced its Advisory Council and location for the highly anticipated neXus 2027 conference, set to take place from April 13 to 16, 2027. Positioned as a key event for professionals in the medical device industry, this conference promises to foster innovation and heightened safety standards in health technology, drawing participants from various fields including regulatory affairs, clinical practices, and product development. A Premier Gathering of Experts and Innovators AAMI neXus 2027 seeks to build off the successes of its predecessors by emphasizing high-level discussions and networking. Following the inaugural AAMI neXus event in 2024, which attracted hundreds of attendees and was co-sponsored by the Food and Drug Administration (FDA), this next conference aims to deliver cutting-edge programming that reflects the rapidly changing landscape of medical technology. Who’s Who in the Advisory Council This year's Advisory Council features prominent figures from the field, including Bill Broadbeck of STERIS and Scott Colburn from FDA/CDRH. Together with representatives from renowned organizations like Boston Scientific, Medtronic, and Google Health, these leaders will collaborate on critical topics for the conference, ensuring that discussions are relevant to current challenges and future opportunities in the medical device sector. The Significance of Diverse Perspectives Inclusivity will be a cornerstone of the neXus 2027 agenda. As the medical device industry continues to evolve, incorporating voices from regulatory agencies and tech companies can help address multifaceted challenges. Understanding various perspectives is not just useful; it’s essential. As highlighted in AAMI's previous events, learning from divergent viewpoints can yield significant insights into improving safety and efficacy within health technology. Focus Areas That Matter: What Attendees Can Expect This year’s programming will cover critical topics such as artificial intelligence, cybersecurity, and best practices in quality assurance and compliance. For professionals in the medical device ecosystem—including those focused on digital health, human factors, and sterilization—AAMI neXus 2027 will provide actionable insights and strategies that can be implemented within their organizations. Participants will benefit from engaging panels, workshops, and networking opportunities designed to bolster both professional development and industry collaboration. Making Your Voice Heard: Call for Proposals AAMI is actively encouraging experts to contribute to the program through their Call for Session Proposals. This is a chance for professionals to share their practical experiences and insights, making the conference not just a spectator event but an interactive learning opportunity for all involved. Topics like regulatory interpretation and innovative strategies for overcoming quality and safety challenges are particularly welcome, reflecting the ongoing need for fresh perspectives in the medical device industry. The Heart of the Matter: Next Steps and Opportunities As excitement builds toward AAMI neXus 2027, participants are advised to stay tuned for further announcements regarding registration and sponsorship opportunities. Whether you're a regulatory professional, a researcher, or a developer, this conference is designed to enhance collaboration across the medical ecosystem. Don’t miss the opportunity to be part of a transformative dialogue that shapes the future of medical technology.

07.28.2026

How the MNDR and Jospong Partnership is Set to Transform AI-Powered Healthcare in Ghana

Update Revolutionizing Healthcare: The Impact of the MNDR and Jospong Joint VentureThe establishment of MHNS Ghana Limited, a joint venture between Mobile-health Network Solutions Inc. (MNDR) and the Jospong Group, marks a transformation in the healthcare landscape of Ghana. This venture is poised to introduce an AI-powered digital healthcare ecosystem that not only leverages MNDR's cutting-edge technology but also integrates Jospong's extensive local expertise and accessibility. As key stakeholders gather to witness this collaboration unfold, it's essential to examine the potential implications for healthcare delivery in the region.Understanding the Technology at PlayAt the heart of this joint venture is MNDR's proprietary technology. The digital healthcare platform is designed to streamline patient care by enabling services like teleconsultation and data analytics. In a country where accessibility to medical professionals can be a significant challenge, such technology could bridge vital gaps, making healthcare more efficient and patient-centered. The anticipated phase one rollout will involve localizing the technology, onboarding initial healthcare providers, and initiating pilot services, setting the stage for broader implementation.A Rooted Approach: Local Leadership and GovernanceOne of the standout features of this joint venture is the balanced governance structure. With both MNDR and Jospong represented on the board, strategic decisions will consider both local and technological perspectives. Jospong's leadership will handle regulatory adherence and local stakeholder engagement, which is critical in a sector as sensitive as healthcare. Such local execution is expected to foster trust and ensure compliance with Ghanaian healthcare regulations, thus enhancing the operational credibility of the new venture.Expanding Horizons: Future Trends and PredictionsThis joint venture is not merely about launching in Ghana; it lays the groundwork for future expansion into sub-Saharan Africa. By establishing a model capable of regional replication, MNDR and Jospong reflect a strategic foresight in leveraging local conditions and regulatory frameworks to navigate broader markets. Analysts predict that the success of this initiative could inspire similar partnerships across the continent, potentially revolutionizing healthcare systems in nations with similar demographics and challenges.Addressing Concerns: Cybersecurity and Data ComplianceAs digital healthcare solutions proliferate, cybersecurity and data protection become paramount. The MNDR and Jospong venture is committed to confidence-building measures that include robust cybersecurity and business continuity strategies. Ensuring patient data privacy and compliance with healthcare regulations will not only protect user information but also cultivate a culture of trust among patients and providers.The Bigger Picture: The Role of AI in HealthcareThe advantages of integrating AI into healthcare are manifold. From predictive analytics that can forecast patient needs to streamlined processes improving overall operational efficiency, the impact of AI cannot be understated. This joint venture exemplifies how embracing technological advancements can lead to improved health outcomes and more effective healthcare systems. As AI continues to evolve, healthcare delivery models will likely transform in ways that further enhance patient experiences.Taking Action: What This Means for StakeholdersFor healthcare providers, policymakers, and patients alike, this joint venture represents a call to action. It emphasizes the need for collaboration between technology companies and local entities to foster innovation while respecting local contexts and regulations. Stakeholders must consider how support for such initiatives could yield long-term benefits for the healthcare sector in Ghana and beyond.This collaboration between MNDR and Jospong is a case study in harnessing technology to address real-world challenges in healthcare access and delivery. As this new system rolls out, the healthcare landscape of Ghana could significantly shift towards more efficient, patient-focused solutions that are scalable throughout the region.

07.24.2026

Cosmo's Recurring Revenue Soars: A Bright Future for Healthcare Innovation

Update Cosmo Pharmaceuticals Achieves Major Milestones in 2026Cosmo Pharmaceuticals N.V. (SIX: COPN), a frontrunner in AI-driven healthcare, has revealed impressive financial results for the first half of 2026. Reporting a robust 18% year-on-year growth in recurring revenues, Cosmo underscores the resilience and diversification of its revenue streams, largely driven by successes in its flagship products—Winlevi® and Lialda®.Impressive Revenue Growth Reflects Strategic AdvancementsIn a detailed report, Cosmo indicated that recurring revenue from Winlevi® surged by 38%, while Lialda® reported growth of 35%. This financial performance reflects not only the company’s operational efficiencies but also the growing demand for innovative treatments in dermatology and gastrointestinal health. The contract development and manufacturing organization (CDMO) segment also grew by 14%, demonstrating Cosmo's increasing foothold in the health sector.Innovations on the Horizon: Clascoterone Topical SolutionA significant highlight for Cosmo is its advancement in dermatological therapies, particularly with Clascoterone 5% topical solution, which is nearing regulatory submission. The latest Phase III clinical data have shown encouraging results, indicating sustained efficacy and safety over a year-long period. The company anticipates submitting applications in the U.S. and Europe, aiming for market launch opportunities that could fundamentally change the treatment landscape for androgenetic alopecia.The GI Genius™ Platform: A Technological Leap ForwardBeyond dermatology, Cosmo is bolstering its gastrointestinal pipeline. The company has recently completed enrollment for a Phase II study of rifamycin SV enema aimed at treating Distal Ulcerative Colitis. Topline results are expected in Q4 of 2026, promising to deliver new insights into effective management strategies for this challenging condition. Furthermore, advancements in the GI Genius™ platform have introduced next-generation capabilities that align with industry demands for more precise diagnostic and treatment modalities, potentially revolutionizing gastrointestinal care.Financial Stability Amid ExpansionDespite significant investments in research and development, Cosmo maintains a robust financial position, concluding the first half of 2026 debt-free and with over €205 million in cash. This financial strength enables the company to pursue its pipeline aggressively, ensuring it remains well-positioned in the competitive landscape of healthcare innovation.Looking Forward: Guidance ReaffirmedCosmo has reiterated its guidance for the full year 2026, targeting total revenues of €105-110 million, with recurring revenues projected between €98-102 million. The forecast reflects confidence in the ongoing growth trajectory of its existing products combined with anticipated success from its regulatory submissions.Implications for Stakeholders and InvestorsThe impressive growth and strategic advancements made by Cosmo Pharmaceuticals present compelling implications for stakeholders and investors alike. As the sector increasingly leans toward technology-driven health solutions, Cosmo's commitment to innovation positions it favorably within the biotech industry. For investors, the current trajectory indicates not only stability but potential for significant returns, particularly as new therapies enter the market.Conclusion: An Exciting Future AheadWith a solid foundation and a clear pathway for future growth, Cosmo Pharmaceuticals is a company worth watching. The advancements in its product pipeline, coupled with a strong financial backing, suggest that it is strategically poised to shape the future of healthcare innovation. As we anticipate the outcomes from its upcoming studies and regulatory submissions, stakeholders should remain engaged with these developments, recognizing the potential impact on patient care and market dynamics.

Where Conventional Meets Natural for a Healthier You

Parallel Health World News offers clarity and actionable knowledge for those eager to harmonize the best of both medical worlds, helping its audience achieve a truly integrative approach to health and wellness.

Advertise
Parallel Health World News
SeamanDan.com
Dan Seaman Media Press Pass

ABOUT US
SeamanDan LLC is a modern news media agency creating niche digital channels that inform and engage. We specialize in launching focused platforms that deliver impactful content.  Our current brands include:
Parallel Health World
AI Insights Hub
MLM News AI
Rider Safe News
Meme Crypto News
Rugged Trails Network
Recreation Wave
Outdoor Odyssey News
Eco-Innovation Hub
Metal Green Innovators
Autism Foundation News

At SeamanDan LLC, we don't just report the news we create platforms that build communities, foster trust, and drive forward-thinking conversations.  Can we build a channel for you?

© 2026 Parallel Health World News All Rights Reserved. 810 N Main St #187, Spearfish, SD 57783 . Contact Us . Terms of Service . Privacy Policy

{"company":"Parallel Health World News","address":", ,  ","city":"","state":"","zip":"","email":"seamandan@seamandan.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*